Latest Updates

(Year 2022)


13-Apr-2022 (NO. SP PPUM: 140/2022)

Medication Supply Disruption: Ephedrine 30mg/1mL Injection

Supply disruption is due to supplier issues.The alternative supply is predicted to arrive in stages by May-2022.Stocks in the Pharmacy are at a minimum level.Suggested alternative: Noradrenaline 4mg/4mL Injection

07-Apr-2022 (NO. SP PPUM: 126/2022)

Medication Supply Disruption: Normal Immunoglobulin 2.5g Injection (Updated)

With reference to the previous circular (No. SP PPUM: 038/2022), we are still facing supply disruption and the stocks in the Pharmacy are at a very critical level.Doctors are suggested to postpone IVIG treatment for elective cases as Pharmacy shall be restricting supply to patients with Immune Thrombocytopenic Purpura (ITP), Kawasaki Disease and critical cases only.

02-Mar-2022 (NO. SP PPUM: 084/2022)

Medication Supply Disruption: Orphenadrine 60mg/2mL Injection

The existing stocks that the Pharmacy Department had expired in Feb-2022.New stocks are predicted to arrive either in Apr-2022 or in May-2022.

02-Mar-2022 (NO. SP PPUM: 083/2022)

Medication Supply Disruption: Phenobarbital 200mg/1mL Injection

New stocks are predicted to arrive either in Apr-2022 or in May-2022.Suggested alternative: Phenytoin 250mg Injection

10-Feb-2022 (NO. SP PPUM: 053/2022)

Medication Supply Disruption: Amoxicillin 875mg Clavulanate 125mg Tablet

Supply disruption is due to temporary out of stock.Supplier is unable to predict when the stocks will resume.Suggested alternative: to add Amoxicillin 500mg Capsules to Amoxicillin 500mg Clavulanate 125mg Tablets

10-Feb-2022 (NO. SP PPUM: 052/2022)

Deletion of Drug from Formulary: Etomidate 20mg/10mL Injection

Supply disruption is due to manufacturing issues.Supplier is unable to predict when the stocks will resume and hence it was decided that the Pharmacy Department will permanently stop the procurement of this drug.

31-Jan-2022 (NO. SP PPUM: 038/2022)

Medication Supply Disruption: Normal Immunoglobulin 2.5g Injection

Supply disruption is due to increased global usage.Supplier predicts that limited stocks will arrive in stages by Feb-2022, however there is no confirmation when stocks will be replenished.Pharmacy shall be restricting supply to patients with Immune Thrombocytopenic Purpura (ITP) and Kawasaki Disease only for the time being.

11-Jan-2022 (NO. SP PPUM: 012/2022)

Sennosides 7.5mg Tablet

In the midst of LPO (Local Purchase Order) process - will take time for its approval and subsequently its distribution to the Pharmacy Department.Suggested alternatives: Lactulose Solution, Bisacodyl 5mg Tablets

11-Jan-2022 (NO. SP PPUM: 011/2022)

Oestrogen (Conjugated) 0.625mg per G Vaginal Cream

Global shortage and no equivalent alternatives in the UMMC Formulary. Supplier predicts that stocks will resume by Feb-2022.